OSR Holdings Inc

OSR Holdings, Inc. develops a portfolio of therapies and healthcare solutions in the United States, Europe, and South Korea. The company develops immunotherapy products, including VXM01, VXM04, VXM06, VXM08, and VXM10 for cancer treatment; DRT102-sp for the treatment of lumbar stenosis, disc herniaton, and spinal; DRT102-dt for dental augmentation; DRT102-nu for nonunion bone fracture; and DRT101 for osteoarthritis. It also provides medical devices. The company is based in Bellevue, Washington.